Healthtech company, Dedalus to create 100 jobs in Ireland

Dedalus, Europe’s leading healthcare software provider, has announced it will create 100 new high-value jobs in Ireland over the next four years as part of a €10 million expansion of its Irish operations. The investment, supported by IDA Ireland, was announced by Taoiseach Micheál Martin TD.

The expansion will bring Dedalus’s total Irish workforce to 150 people, scaling its presence across software engineering, product management, clinical informatics, data and analytics, cybersecurity, and implementation services. It will further embed Ireland at the centre of Dedalus’s efforts to deliver digital health solutions to providers across the country and Europe.

The company currently partners with the HSE and a range of hospitals across the country (see below). In 2021, Dedalus acquired the online healthcare appointment platform Swiftqueue which manages over four million appointments annually across Ireland’s healthcare system.

Taoiseach, Micheál Martin TD said:
“Dedalus’s expansion in Ireland is a welcome boost to our digital health ambitions. These 100 new jobs will support the delivery of better, more connected healthcare services while reinforcing Ireland as a key player in the European health technology ecosystem.”

Minister for Enterprise, Tourism and Employment, Peter Burke TD said:
“Dedalus’s decision to expand its operations in Ireland and create 100 high-quality jobs is very welcome news. It is a strong endorsement of our talent base and our reputation as a hub for innovation in health technology. This investment will strengthen Ireland’s digital health capabilities and contribute to better healthcare outcomes for patients across the country. I thank Dedalus for their continued investment and wish the team every success as it grows and continues to deliver innovative solutions.”

Cathy McCartan, Executive Director, Dedalus Healthcare Ireland, said:
“Ireland is central to our mission to help healthcare systems deliver safer, more connected care. This investment allows us to expand our Irish team and capabilities—supporting hospitals and community services with interoperable electronic health records, diagnostics and imaging platforms, clinical decision support, and integration services. By helping unlock the full value of Ireland’s healthcare data, we can improve outcomes for patients, strengthen system-wide decision-making, and deliver real value to the country. We’re excited to grow here and to export Irish-led innovation across our wider European network.”

Michael Lohan, Chief Executive, IDA Ireland, said:
“Dedalus’s decision to expand in Ireland underscores IDA Ireland’s track record and reputation as a leading location for digital health and enterprise software. These highly skilled roles will contribute to innovation in patient care and strengthen Ireland’s position within a dynamic European health-tech sector. IDA Ireland is pleased to support this investment and looks forward to Dedalus’s continued success.”

The announcement comes as Dedalus continues to support some of the most significant digital health initiatives ever undertaken in Ireland. This year alone, the company has collaborated with healthcare partners on a range of major national initiatives, including:

  • Beaumont Hospital: go-live of new clinical applications with 3,000 hospital staff trained and using the system.
  • St James’s Hospital: modernisation of laboratory information management systems, processing over 12 million tests annually.
  • National Medicinal Product Catalogue: a central reference source for medicines and medical devices, promoting safer, more consistent prescribing, strengthening monitoring and planning, and enabling more joined-up care for patients.
  • National Terminology Service: the country’s first such service, now live, transforming how medical data is classified and harnessed across the health system.
  • National Data Dictionary: ensuring all healthcare professionals use the same definitions and language across care delivery.
  • Regional Contracts: supporting regionalised care with the deployment of digital systems across the Mid-West and West/North-West regions.

Dedalus is Europe’s only large-scale provider of electronic health records (EHRs), with applications used in the care of one in three European citizens. The company’s strong European roots offer Irish patients and policymakers the added assurance that data remains within Europe, fully compliant with EU data protection laws.

The company is actively shaping European digital health policy through its leadership in initiatives such as the European Health Data Space (EHDS) and the European Electronic Health Record Exchange. Its AI tools are developed using European health data and are fully aligned with the EU AI Act, ensuring ethical, secure, and localised innovation.

Dedalus is also the only large-scale EHR vendor that is an active member of OpenEHR International, the global community and standards organisation that develops and maintains specifications for the design, exchange, and storage of health records.

Top Healthcare Analytics Companies in 2025

The rapid digitalization of the healthcare sector has brought data to the forefront of clinical decision-making, operational efficiency, and patient outcomes. Healthcare providers, digital health startups, research institutions, and payers now rely heavily on intelligent data tools to extract value from vast volumes of clinical, administrative, and patient-generated information. Healthcare analytics companies are leading this transformation, offering solutions that improve care quality, reduce costs, enable interoperability, and support population health management. Below is a detailed list of the top healthcare analytics companies in 2025 that are redefining the future of data-driven healthcare.

1. Kodjin

Kodjin is an advanced, FHIR-native healthcare data analytics platform designed to help healthcare organizations unify fragmented data sources, standardize datasets, and generate actionable insights in real time. Built by Edenlab, Kodjin solves a core problem in healthcare: lack of interoperability and the difficulty of transforming raw medical data into structured, analyzable formats. 

The platform incorporates a powerful FHIR engine, ensuring compliance with global data standards while enabling seamless exchange of clinical information across systems, applications, and care environments. Kodjin empowers hospitals, payers, and digital health vendors with dashboards, predictive models, query tools, and analytics workflows that support population health analysis, operational management, clinical decision-making, and regulatory reporting. With its focus on clean data, speed, security, and scalability, Kodjin positions itself as a cornerstone solution for organizations undertaking digital transformation, building health information exchanges, or implementing modern data architectures.

2. Optum

Optum is one of the most established names in healthcare analytics, offering robust data intelligence solutions for providers, payers, and life sciences organizations. Leveraging one of the largest healthcare datasets in the world, Optum delivers insights that support predictive risk modeling, chronic disease management, and operational optimization. Its analytics tools help healthcare systems identify care gaps, improve value-based care performance, and reduce unnecessary utilization. Optum’s long-standing expertise, combined with AI-driven analytics and deep clinical datasets, makes it a trusted partner for organizations seeking to enhance care quality and efficiency.

3. SAS Institute

SAS Institute is a global leader in advanced analytics and AI-driven health intelligence. Its healthcare suite uses machine learning, statistical modeling, and data science to support clinical research, population health initiatives, and hospital management. Healthcare organizations rely on SAS for fraud detection, epidemiological modeling, outcome prediction, and quality improvement. With decades of experience in data analytics and an unmatched record in trustworthy algorithms, SAS empowers medical researchers and health systems to uncover patterns and derive insights that lead to evidence-based improvements in care.

4. Health Catalyst

Health Catalyst provides cloud-based analytics and data warehousing solutions specifically tailored to the healthcare sector. The company helps organizations aggregate, normalize, and analyze data from across clinical and administrative systems. Health Catalyst’s platform is widely recognized for driving measurable improvements in operational performance, cost reduction, and patient outcomes. Their tools support decision-making across quality metrics, financial operations, and patient experience. By focusing on outcome-driven analytics and real-world implementation, Health Catalyst stands out as a leading partner for hospitals aiming to accelerate digital transformation and enhance clinical efficiency.

5. IQVIA

IQVIA is a powerhouse in healthcare analytics, blending real-world data, artificial intelligence, and life sciences expertise. Known for its extensive datasets and advanced data modeling, IQVIA supports pharmaceutical companies, researchers, and health providers with tools for real-world evidence analysis, clinical trial optimization, and patient journey insights. Their platform enables organizations to analyze treatment effectiveness, improve drug development processes, and strengthen population health strategies. IQVIA’s unique ability to integrate clinical, genomic, and behavioral data makes it a foundational analytics partner for organizations focused on precision medicine and innovation.

6. Truven Health Analytics (IBM Watson Health)

Truven Health Analytics delivers evidence-based insights powered by AI and natural language processing through IBM Watson Health technologies. The company provides analytics solutions for population health management, clinical benchmarking, and operational efficiency. Truven’s tools allow hospitals to evaluate performance, improve patient safety, and align care delivery with national quality standards. Government agencies and employers also rely on Truven for policy evaluation and cost analysis. With strong analytical capabilities and a focus on actionable intelligence, Truven helps healthcare systems make informed decisions that improve outcomes and reduce costs.

7. MedeAnalytics

MedeAnalytics provides enterprise analytics solutions designed to help healthcare organizations strengthen both financial and clinical operations. Its platform offers real-time dashboards, revenue cycle analytics, and population health tools that enable healthcare leaders to uncover inefficiencies and identify improvement opportunities. MedeAnalytics focuses on intuitive data visualization, giving stakeholders at all levels—from executives to clinical managers—the ability to interpret data quickly and effectively. Their predictive analytics solutions also support resource planning, patient engagement, and quality improvement initiatives. By turning complex data into clear, actionable insights, MedeAnalytics enables organizations to achieve measurable performance enhancements.

Conclusion

The healthcare analytics landscape is becoming increasingly vital as organizations navigate growing data requirements, regulatory pressures, and the shift toward value-based care. Each company on this list plays a crucial role in advancing data-driven healthcare—whether through enhanced interoperability, predictive modeling, research analytics, or operational intelligence. Kodjin, with its FHIR-native architecture and focus on real-time data standardization, stands out as a leader for modern healthcare ecosystems seeking scalable and future-proof analytics solutions. Together, these top healthcare analytics companies empower the industry to improve patient outcomes, increase efficiency, reduce costs, and accelerate innovation. In a world shaped by digital health, analytics is not just a tool — it is the foundation of smarter, safer, and more efficient care delivery.

 

Top Healthcare Data Analytics Companies Driving Insights in 2025

In today’s rapidly evolving healthcare environment, data has become a critical asset. Organizations are seeking to harness clinical, operational and claims information to drive better outcomes, reduce costs and improve patient experiences. Healthcare data analytics firms play a vital role in this transformation—offering platforms, services and expert guidance that turn raw data into actionable intelligence. Here are seven leading companies that stand out in the healthcare data analytics space.

1. Edenlab

Edenlab specializes in healthcare data architecture, interoperability, analytics platforms and decision‑support systems connecting disparate data sources—clinical, claims, monitoring and administrative. As trusted providers of healthcare data analytics solutions, they help healthcare organizations build scalable data lakes, clinical data repositories, ETL pipelines and analytics engines that enable real‑time insights, predictive modelling and population health management. 

Their expertise in FHIR, large‑scale data processing and custom analytics has enabled providers and payers to consolidate fragmented data ecosystems, improve data governance and extract value across the care continuum. With consistent emphasis on performance, scalability and compliance, Edenlab is a partner of choice for health systems looking beyond dashboards to embedded analytics and intelligence.

2. Health Catalyst

Health Catalyst is a well‑known analytics firm dedicated exclusively to healthcare. Their platform brings together clinical, financial and operational data to support performance improvement across care delivery, cost management and regulatory reporting. With extensive experience spanning hundreds of health systems, Health Catalyst provides robust analytics libraries, machine‑learning models and workflow integration to help clients move from data to outcomes. Their strength lies in helping clients embed analytics into clinical and administrative workflows, enabling care teams to act on insights rather than just view them.

3. Innovaccer
Innovaccer offers a data activation platform designed for providers, payers and digital health innovators. Their technology connects multiple data sources—EHRs, claims, patient‑generated data and social determinants—to provide a unified patient record, analytics and care‑management tools. Through predictive risk modelling, care‑gap identification and segmentation analytics, Innovaccer helps healthcare organizations transition to value‑based care, optimize provider performance and engage patients. Their focus on data readiness, workflow integration and actionable insights positions them as a strong player in the data analytics market.

4. CitiusTech
CitiusTech is a global healthcare technology firm offering data management, consulting and analytics services. Their healthcare data analytics capabilities span advanced visualizations, predictive modelling, AI/ML integration and cloud‑based data platforms. They serve payers, providers and life‑sciences companies wishing to scale data analytics initiatives, unify fragmented systems and derive business value from large volumes of healthcare data. With deep domain experience and consulting capability, CitiusTech helps organizations build analytics road‑maps, accelerate time‑to‑insight and optimize both clinical and financial performance.

5. Merative (formerly IBM Watson Health)
Merative brings decades of experience in data, analytics and AI for the healthcare sector. Their solutions leverage clinical, genomic and real‑world evidence data to provide insights for providers, life sciences firms and research organizations. Through analytics‑enabled decision support, outcomes modelling and cost‑quality optimisation, Merative supports clients in translating data into strategic action. Their global footprint and strong product ecosystem make them a key choice for healthcare data‑analytics needs with scale and complexity.

6. Datavant
Datavant is a healthcare data and analytics infrastructure company whose core strength lies in linking and harmonising data across healthcare participants—providers, payers, research institutions and technology firms. By enabling secure data exchange and establishing linked ecosystems, Datavant allows clients to derive deeper analytics from integrated datasets rather than isolated silos. Their focus on data connectivity, de‑identification and analytic readiness supports advanced use cases such as population risk modelling, real‑world evidence generation and operational benchmarking.

7. Sophia Genetics

Sophia Genetics may be known for its genomics platform, but its analytics capability spans imaging, clinical and molecular data to deliver insights for hospitals, laboratories and biopharma. Their data‑driven medicine platform combines multi‑modal analytics and machine learning to enable precision diagnostics and actionable insights. While niche, their expertise represents a growing frontier in healthcare data analytics—where deep biomedical data is fused with analytics to move from population care to personalised medicine.

Conclusion
Healthcare data analytics is no longer a nice‑to‑have—it’s a strategic imperative. By integrating, modelling and interpreting data across clinical, operational and population domains, organisations can gain the insights needed to refine care delivery, reduce cost, engage patients and meet regulatory challenges. The companies listed above represent the leading edge of this field, offering platforms and services that transform data into actionable intelligence.

Among them, Edenlab stands out for its strong focus on scalable healthcare analytics architecture, interoperability and custom analytics solutions. Their healthcare data analytics solutions offering enables healthcare organisations to move from scattered data to strategic insight and improved decision‑making. As data volumes swell, regulatory demands increase and value‑based care intensifies, partnering with an experienced analytics firm becomes critical for turning data into impact.

 

OxygenCare expands Digital Healthcare offering with Medanets

OxygenCare is delighted to announce the introduction of the Medanets integrated Point of Care Nursing app to its ever-expanding Digital Healthcare solutions portfolio. The collaboration brings together two companies with a shared vision for improving patient care through innovative digital healthcare solutions.

Stephen Nicholson, Digital Health Manager, OxygenCare, explains: “Medanets simplifies nursing routines, supports decision making, complements and integrates with EHR systems, and releases time to care for patients.’ The CE and MDR certified app was developed in collaboration with healthcare professionals.

OxygenCare is a multi-award-winning, family-owned business with over 50 years supporting healthcare throughout the island of Ireland.

“Their dedicated digital health team and prior experience in delivering complex ICU and anaesthesia systems make them an deal partner for us,” says Medanets CEO Juha-Matti Ranta. “On top of that, their deep market knowledge and the impression made by their team further solidified our confidence in this partnership. It seems we are a natural fit in both values and working style.”

For over 30 years, OxygenCare has been transforming digital healthcare through clinical systems and working with innovative products and solutions throughout Ireland. The Medanets integrated nursing app supports point-of-care documentation and immediate access to key patient data, making it a natural fit with OxygenCare’s digital portfolio.

Combining OxygenCare’s connectivity solutions with Medanets’ mobile solutions can provide significant added value both to organisations already using an electronic health record (EHR) and to hospitals beginning their digital journey.

“We can offer healthcare providers a fast-track way to modernise operations, even in settings where an EHR is not yet in place. For instance, Medanets supports “lightweight IT” approaches such as sending PDFs directly to a document archive—a direct impactful step forward in digital empowerment,” Ranta explains.

Maurice Moran, Managing Director of OxygenCare, 
adds: “This Medanets offering complements our portfolio, and we see strong market potential. Together, we are currently conducting exploratory efforts in the market to identify opportunities and tailor our approach to local needs. Through this new partnership, all care phases can be managed digitally through a single provider. This partnership marks a promising step toward improving healthcare outcomes in Ireland and underscores the strength of collaboration in driving innovation forward.”

Temporary Doctor Placements: A Key to Sustainable Healthcare Delivery

People face several challenges when it comes to getting medical care. Cost is certainly a major factor here, and many patients can’t afford insurance to help cover the costs. That’s a bit of a vicious cycle in its own right, but it’s only one of the hurdles standing between people and the medical care they need. In many areas, there just aren’t enough clinics and doctors to go around. At the same time, a lack of diversity in healthcare teams leads to misunderstandings, mistrust, and many other problems. 

Today’s healthcare facilities are up against an array of challenges as well. One of the most significant is a growing shortage of doctors and nurses. It’s among the main reasons why hospitals and clinics are struggling to provide care for everyone in their communities. It’s also playing a role in driving up the costs of care. That said, medical facilities can use temporary doctor placements to help combat those problems and many others. 

Offsetting Staffing Shortages

For one, locum tenens providers can help offset the ongoing shortage of medical professionals. It’s affecting medical facilities across the country, but it’s particularly difficult for hospitals and clinics in rural and underserved areas. Bringing in doctors to fill temporary roles can help bridge the resulting gaps. Locum tenens providers can step in when medical facilities experience upticks in the demand for care or have vacant roles that need to be filled until they can find permanent team members. That, in turn, allows them to better meet patients’ needs. 

Preventing Burnout

One of the reasons for the growing shortage of healthcare workers is burnout. Doctors and nurses have heavy workloads and often need to work long hours. To make matters even more difficult, medical facilities that are dealing with staffing shortages may not be able to give their team members time off when they need it.

Those issues are causing quite a few people to leave the medical field. They’re also contributing to high turnover rates for medical facilities. Locum tenens providers can help lighten the load and enable medical facilities to give their permanent team members much-needed time off. That can help reduce burnout and turnover rates. 

More Access to Specialized Care

Additionally, locum tenens providers can enable medical facilities to give their patients better access to specialized care. Many medical facilities, especially smaller ones and those in the areas hit hardest by the ongoing shortage, don’t have full-time specialists in certain fields on staff. As such, they may not be able to provide all the care their patients need. For those that are dealing with issue, locum tenens providers who specialize in different fields can temporarily step in to help. They can allow medical facilities to provide more inclusive services for their patients without having to keep permanent specialists on staff. 

Giving Patients a Higher Quality of Care

Both medical facilities and their patients are being affected by the ongoing shortage of healthcare professionals and rising costs of care. Though those in some areas are feeling the effects more than others, no corner of the country is immune to the effects. Locum tenens providers are one of the keys to more sustainable healthcare delivery. They can fill temporary needs that arise due to many circumstances. In doing so, they enable medical facilities to better meet their patients’ needs as well as those of their permanent team members. 

Hollister Ballina transforms into ‘epicentre of global expertise’ with €80m investment

Hollister Incorporated, a global leader in ostomy, continence, wound care and critical care products has announced an €80m R&D investment and a digital transformation project that will create approximately 50 new jobs in Ballina.

The multimillion-euro investment aims to elevate Ballina into a global epicentre of expertise through novel device design and extensive site-wide training, setting a benchmark for digital transformation within Hollister’s global network.

This project is supported by the Irish Government through IDA Ireland.

Minister for Social Protection and Minister for Rural and Community Development and the Gaeltacht  Dara Calleary TD said: “This is a terrific day for Ballina and North Mayo with the announcement of 50 additional jobs for the region. Hollister is more than just a manufacturing plant in Ballina; it is one of the mainstays of our community. Today, second and third generations of families are employed there boosting the local economy and contributing to the everyday life of the town. I want to pay credit to Shane Caher and all of the staff in Hollister who have dedicated themselves to Ballina and to the West of Ireland but also to all of the past Hollister management and staff who’s work, and commitment is the foundation of the plant’s success today. Finally, I would like to acknowledge  IDA  Ireland for their continued support to Hollister and across Mayo. I very much look forward to what the next 50 years will bring for Hollister and Ballina”

Minister of State at the Department of Enterprise, Tourism and Employment, Alan Dillon TD, said“This €80 million investment by Hollister Inc. is very welcome news. It is a powerful endorsement of Ballina’s skilled workforce and Ireland’s reputation as a hub for innovation in healthcare manufacturing. To see a long-standing employer, like Hollister, continue to grow and evolve through cutting-edge research and digital transformation is very encouraging. The creation of 50 new high-quality jobs will also bring economic and social benefits to the region. On behalf of the Irish Government, I thank Hollister for its continued commitment to Ballina and the West of Ireland, and I wish the team there the very best for the future and many more years of success here in Co. Mayo.”

Founded in 1921 in Illinois, the US MedTech manufacturer has been part of the fabric of Ballina since 1976, where it now employs almost 1000 people.

Hollister is currently recruiting in the areas of Engineering, Data Science and Business Services.  To explore opportunities, visit Career Opportunities | Hollister IE

“We are thrilled to announce this significant milestone for Hollister Incorporated. Our commitment to innovation and excellence continues to drive us forward, and this investment in our research program and digital transformation project is a testament to the hard work and dedication of our entire team,” said Shane Caher, Senior Director of Plant Operations and General Manager. “We look forward to the exciting opportunities that lie ahead as we continue to deliver on Our Mission to make life more rewarding and dignified for those who use our products and services.”

IDA Ireland CEO Michael Lohan said: “Since 1976, Hollister has been creating jobs and investment in Co. Mayo.  In the intervening near 50 years, Hollister has again and again committed to and delivered on its ambitions for its Irish operations.  Supporting Hollister and companies across IDA Ireland’s client portfolio with R&D investment and digital transformation endeavours sits right at the heart of Adapt Intelligently: A Strategy for Sustainable Growth and Innovation 2025-29.  I wish to congratulate Hollister and assure them of IDA Ireland’s continued support.”

Key Metrics To Track When Working With A Healthcare PR Agency

If your hospital is struggling to build a credible reputation in the market, then you can consider working with a healthcare PR agency. Why? This can be a strategic investment that will go a long way in elevating your organisation’s image, building trust with important stakeholders, and eventually helping you in achieving and driving the objectives of your platform. 

However, you need to be sure that you get the most out of this partnership; it’s crucial to outline and monitor the key performance indicators or metrics. What do these metrics do? Well, they provide you with loud evidence of whether your facility is creating an impact while assisting you in assessing the return on your investment. 

Questions like “What are those key metrics?” might have popped into your mind. Don’t worry, as this blog is here to give you the relevant details related to the necessary metrics you need to track while collaborating with this PR agency. 

Media Relations and Visibility 

Media relations and visibility are the categories that pay immense attention to your platform’s ability to grab and secure positive media coverage, as that can do wonders in boosting your entity’s visibility in the long run as well. How is it done? Let’s discuss:

Number of Media Placements

In this situation, the number of media placements plays a massive role. How? This metric tracks the number of times your company or its name was mentioned in various relevant media outlets. This can be in the shape of online, print, and broadcast, providing a solid number to confirm if the agency’s efforts are fulfilling the purpose or not. 

Quality Of Media Placements 

Yes, on one side, quantity matters, but at the same time, you can’t ignore the quality of media placements. Therefore, you need to keep the following factors in mind:

Type of Publication

You need to stay vigilant and check the type of publication the agency is getting you published in. For instance, your platform should get covered in extremely respected publications, national news outlets, or influential blogs that have a huge target audience. Why? The reason is that these spaces add more weight as compared to watching your company’s name and images in smaller, less relevant magazines that wear the label of non-existence. So, if you are trusting their efforts, then this should be there. 

Outlet Should Be Relevant

The agency shouldn’t be reaching out to random media outlets but the ones whose following is relevant to your target patient. For instance, it will be best if people like health care professionals, policymakers, or other well-known stakeholders follow the media outlet. 

Analyze The Tone

Even if your medical organisation is receiving the desired media coverage, analyze the tone and sentiment of the situation. Examine whether it is negative, neutral, or positive, as you certainly won’t pay them for doing negative publicity. Hence, the PR agency should not leave any stone unturned in providing your company with either exceptionally positive or balanced reporting. 

Inclusion of Key Message 

You will want the key message of your medical facility to be correctly expressed in front of the media. Hence, keep your eyes open to see whether the healthcare PR agency is standing by their commitment as they promised, meaning does their team accurately communicate about your value propositions, and highlight or not. 

Placement and Prominence

When your hospital’s name appears in a feature article, you can expect it to attract more views than just getting briefly mentioned in a broadcast segment. Hence, while working with a healthcare PR agency, see where their teams are mentioning your platform. 

Media Reach and Impressions

You must have read about the terms impressions and reach, but you won’t know what they stand for. Impressions are another critical metric that gives the total number of times your hospital’s coverage was viewed. While reach shares the unique number of individuals who could have seen or heard about your hospital’s coverage. How are these rough figures calculated? It is done on the basis of circulation figures, the amount of traffic the particular website receives, or the number of viewership of all the relevant media options. 

Content Marketing and Thought Leadership 

Does your healthcare PR agency offer content marketing and thought leadership ideas in its package? If so, then be ready to track the following metrics: 

Website Traffic and Engagement

After the PR agency posts some interesting content on your hospital’s site, you need to monitor changes on the website. For instance, look at the overall visits of the target audience you tried to reach, any unique visitors that were compelled to read through the posts or blogs on your website, the rate of bounce, and how much time is spent on your page. And from what source is this traffic coming from, such as organic, referral, or direct? In this way, you can assess the PR agency’s efforts to determine whether the partnership was a waste of time and money. 

Performance Of The Blog 

If the PR agency has filled your website’s blog section with plenty of blogs, then track the content’s performance. For instance, you should see how many views, comments, and shares the information receives. Plus, the time spent on the page.  

Engagement on Social Media

Social media is seen as a vital tool, so the PR agency may use it for creating social media posts or promotional activities. Therefore, monitor metrics in the form of likes, shares, comments, and reach to know that their team’s efforts are working out. 

Conclusion

We hope you are clear regarding the key metrics you need to check while working with a healthcare PR agency. Therefore, after signing a deal, try to follow as suggestions so you don’t end up wasting time and money. 

Biotech firm with obesity ambitions: We aim for an agreement within a few years

The Danish-founded biotech company Pila Pharma looks to secure a partnership or acquisition within the next few years. The short-term goal is to advance the development of a promising new drug candidate for the treatment of obesity and diabetes.

Pila Pharma, listed on the Nasdaq First North stock exchange in Stockholm, has set a clear strategy for the future: Within a few years, the company aims to be acquired by or partner with an industry player capable of furthering and realizing its research in obesity and other metabolic diseases using TRPV1 inhibitors. The goal is to ensure that Pila Pharma’s potential new weight-loss pill reaches the market as quickly as possible.

– We have a promising drug candidate with a completely different side effect profile compared to other treatments currently in development or on the market. Our ambition is to progress the candidate over the next few years and then hand it over to a larger player who can take it to the next level. The global market is in dire need of effective obesity treatments, particularly scalable pill-based solutions, and we believe we could have a role to play in this development, says CEO Gustav H. Gram, adding:

– Since our founders’ discovery in 1999 and the company’s founding in 2014, we have made significant progress and gathered data that suggests we are on the right track. The next major step is to establish proof of concept for weight loss. We are the only company working with this specific type of molecule—TRPV1 inhibitors—as a novel therapeutic approach to treating obesity and other metabolic diseases. If we succeed, I firmly believe we will emerge as a strong and attractive candidate for partnership or acquisition.

A Scalable Pill Solution with a Different Side Effect Profile

Pila Pharma was founded by former Novo Nordisk researcher Dorte X. Gram, who was the first researcher to identify the molecule that later became semaglutide—the active ingredient in Novo Nordisk’s blockbuster drugs Ozempic and Wegovy.

During her tenure at Novo Nordisk, she also discovered— blocking the TRPV1 receptor— could be a potential new mechanism for treating metabolic diseases. With the rise of GLP-1 treatments, Pila Pharma is entering a highly competitive market where unique advantages will determine success.

– In our research and development efforts, we are focused on generating clinical data on the safety and efficacy of XEN-D0501 for treating obesity and related conditions such as diabetes. Patients, physicians, and the industry are all seeking effective weight-loss treatments without common side effects such as nausea, vomiting, and diarrhea. If we can achieve this with an oral solution that can be scaled to meet market demand, we envision a future where more patients have better access to sustainable weight management options, says Dorte X. Gram. She elaborates:

– Approximately one-third of patients worldwide who use GLP-1 medications for severe obesity—such as Wegovy—discontinue treatment prematurely due to side effects, cost, and availability issues. If we can offer a scalable pill alternative based on small molecules, it will significantly improve accessibility and help patients adhere to their treatment plans.

A Major Opportunity for Pill-Based Obesity Treatments

Professor Jens Juul Holst from the Department of Biomedical Sciences at the University of Copenhagen was among the first to discover the GLP-1 hormone in 1986, which plays a key role in stimulating insulin secretion from the pancreas. Today, GLP-1 receptor agonists are used to treat type 2 diabetes and severe obesity.

He sees significant potential for pill-based obesity treatments in certain markets.

– In some parts of the world, injection-based treatments pose a challenge, making a pill a far more attractive option. This is particularly true in Asian and African markets, where needle phobia is widespread, creating an enormous market opportunity. This factor is highly relevant to pharmaceutical companies, many of which avoid investing in injectable drugs due to economic considerations, says Jens Juul Holst.

He also predicts that pricing will play a decisive role in the future:

– With several new drugs on the horizon, if they deliver on their promises, small-molecule pills are poised to become a major success. One key reason is that they can be sold at a significantly lower price point compared to biologic drugs, which require more complex manufacturing, says Jens Juul Holst.

The core asset of Pila Pharma is its TRPV1 inhibitor, XEN-D0501 – an orally administered tablet currently in Phase 2 clinical development. At the end of 2024, the company announced its engagement with regulatory authorities to define the optimal approach for its next clinical trial in obesity and diabetes.

UiPath Expands Healthcare Automation with New Global Professional Services Capabilities for Electronic Medical Records Platform

UiPath a leading enterprise automation and AI software company has announced that it has negotiated a new global consulting agreement with a major Electronic Medical Records (EMR) platform to accelerate professional services programmes for customers in 16 new countries. With the agreement, UiPath significantly expands its professional services capabilities for healthcare organisations and makes customer and partner access to this EMR platform faster and more seamless.

EMRs are the backbone of modern healthcare, connecting patients, providers, and payers with vital information. While these platforms enhance the patient-provider experience, the overwhelming volume of work needed in the EMR means many healthcare providers spend more time with data than with patients, billing administrators are saddled with claims, and IT departments must orchestrate interoperability between services.

With the new agreement, customers and partners can now gain access in days rather than weeks, and UiPath can work more closely with strategic regional partners to provide customers with expanded options in talent and price point. New locations supported beyond the U.S. and Canada include Australia, France, Germany, Italy, Singapore, and Sweden, among others.

Automation and AI can help providers by reducing administrative and clinical abrasion, increasing revenue integrity, and lower costs through optimising interoperability and application testing.

“The EMR market for hospital systems alone is expected to grow beyond $20 billion in 2025, which shows the worldwide dependency on major EMR platforms for providers, payers, and patients. Unfortunately, healthcare costs also continue to rise in parallel. Automation and agentic automation are powerful solutions to lower costs and improve efficiencies,” said Jason Warrelmann, Vice President of Industry Practice at UiPath. “With professional services from UiPath and its qualified partners, healthcare organisations have significantly greater access and resources to drive down costs and automate more end-to-end processes with the ultimate goal of better care and more fulfilling work for healthcare professionals.”

Critically, as agentic automation and agentic AI grow in adoption, UiPath can help customers and partners scale their support for agentic solutions. Agentic automation enables software agents, powered by large language models (LLMs), generative AI (GenAI), and large action models (LAMs), as well as other advanced AI, to take autonomous action. Agentic automation agents can perceive their environment, reason and ask questions about it, and formulate and execute a set of actions to achieve specific goals.

People do not need to structure and direct these agents’ work; rather, agents themselves can assess data, recognise patterns, formulate new questions, draw conclusions, structure processes to get the work done, and execute the work.

Click here to discover how UiPath can drive agentic automation and other automation transformation in healthcare.